Rocket Pharmaceuticals, Inc. (FRA:9IP1)
Germany · Delayed Price · Currency is EUR 2.569
-0.015 (-0.58%)
At close: Dec 19, 2025
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of €298.31 million as of December 22, 2025. Its market cap has decreased by -74.62% in one year.
Market Cap
298.31M
Enterprise Value
129.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.57
Market Cap Chart
Since January 5, 2018, Rocket Pharmaceuticals's market cap has decreased from 343.87M to 298.31M, a decrease of -13.25%. That is a compound annual growth rate of -1.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 298.31M | -76.46% |
| Dec 31, 2024 | 1.27B | -48.17% |
| Dec 29, 2023 | 2.44B | 76.39% |
| Dec 30, 2022 | 1.39B | 12.04% |
| Dec 31, 2021 | 1.24B | -54.45% |
| Dec 31, 2020 | 2.72B | 147.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |